Sector: Pharmaceuticals & Biotechnology

Mid Cap

Neuland Laboratories Share Price

Neuland Laboratories Ltd.

₹13,507

869.00(6.88%)

Invest in NEULANDLAB with up to 2.22x margin.

Trade with MTF

23rd Feb 2026 | 3:28 PM

NSE : NEULANDLAB

Open Free Demat Account

Neuland Laboratories Performance

Price Movement

₹13507.00

₹12727.00

₹13790.00

↘ Today's Low↗ Today's High

1 Year Performance

₹13507.00

₹10190.70

₹19747.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹13,790.00

Low₹12,727.00

Open at₹12,800.00

Prev Close₹12,638.00

Volumes2.53 L

Avg Price₹13,427.66

Lower Circuit₹10,111.00

Upper Circuit₹15,165.00

Historical Performance

3M High₹17,550.00

3M Low₹12,447.00

1 Yr High₹19,747.00

1 Yr Low₹10,190.70

3 Yr High₹19,747.00

3 Yr Low₹1,561.10

5 Yr High₹19,747.00

5 Yr Low₹967.00

Neuland Laboratories Fundamentals

Market Cap

High in industry

17,514.10 Cr.

PE Ratio (TTM)

High in industry

97.80

Dividend Yield

Low in industry

0.10

Net Profit TTM

40% decr over last year

179.13

Net Profit Growth

40% decr over last year

179.13

PEG Ratio

Negative PEG TTM

-2.40

ROE

27% decr over last year

17.06

Operating Revenue TTM

1,575.10

Operating Revenue Growth

2.7% incr over last year

Book Value

High in industry

10.80

MFI

MFI is mid-range

30.23

RSI

RSI is mid-range

39.07

EPS (TTM)

202.74

Debt to Equity

0.09

Face Value

Operating Profit Margin Qtr.

21.59

Operating Profit Qtr.

77.13

Net Profit Qtr.

40.57

Operating Revenue Qtr.

439.71

PB Ratio

10.80

Neuland Laboratories Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	439.71	514.27	292.75	328.36	398.03
Operating Expense	362.78	359.15	258.46	277.61	311.66
Operating Profit	76.93	155.12	34.29	50.75	86.38
Depreciation	23.92	22.54	20.19	16.89	16.30
Interest	6.79	5.34	4.58	2.35	2.22
Tax	13.86	32.58	3.67	11.25	26.15
Net Profit	40.42	96.46	13.71	27.73	101.39

Neuland Laboratories Technicals

Neuland Laboratories Ltd. EMA & SMA

₹13507.00

869.00 (6.88%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹13080.7

Day EMA10 ₹13192.1

Day EMA12 ₹13221.4

Day EMA20 ₹13371

Day EMA26 ₹13517.9

Day EMA50 ₹14084.5

Day EMA100 ₹14520.1

Day EMA200 ₹14230.6

Neuland Laboratories Support and Resistance

Resistance

First Resistance₹12988.00

Second Resistance₹13338.00

Third Resistance₹13556.00

Support

First Support₹12420.00

Second Support₹12202.00

Third Support₹11852.00

Technical Indicators

Day RSI39.07

Day MFI30.23

Day ADX17.49

Day Commodity Channel Index-132.30

William-94.68

Day MACD-296.51

Day MACD Signal Line-338.65

Day ATR650.37

Day ROC125-8.38

Day ROC21-6.87

Neuland Laboratories Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	32.6	32.7	32.7	32.7	32.6	32.6
FII	26.5	23.9	22.1	21.7	20.6	20.9
DII	6.7	9.5	11.4	12	14	14.7
Public	34.1	34	33.8	33.7	32.8	31.8

Neuland Laboratories Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	18.41 K	47.67 K	38.61%
Week	13.8 K	47.04 K	29.34%
1 Month	14.13 K	49.2 K	28.73%
6 Month	17.73 K	58 K	30.57%

Neuland Laboratories SWOT Analysis

Strengths16

Weakness11

Opportunity6

Threats0

Positive Breakout Third Resistance ( LTP > R3)

Benjamin Graham Value Screen

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Year

Expensive Performers (DVM)

PEG lower than Industry PEG

Companies with Low Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

High Volume, High Gain

Stocks in uptrend most likely to cross above SMA-200 soon

Top Gainers

High Volume, High Gain

Volume Shockers

Neuland Laboratories Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
18 Jul, 2025	12	FINAL	18 Jul, 2025	Equity Share
12 Jul, 2024	14	FINAL		Equity Share
11 Jul, 2023	10	FINAL		Equity Share
14 Jul, 2022	5	FINAL	15 Jul, 2022	Equity Share
29 Jun, 2021	3	FINAL		Equity Share
10 Nov, 2020	2	INTERIM	11 Nov, 2020	Equity Share
18 Feb, 2020	2	INTERIM	20 Feb, 2020	Equity Share
27 Jun, 2019	1.2	FINAL		Equity Share
04 Aug, 2016	2	FINAL		Equity Share
06 Aug, 2015	1.5	FINAL		Equity Share

Neuland Laboratories Stock Comparison

Financials	Corona Remedies Ltd.	Sudeep Pharma Ltd.	Rubicon Research Ltd.	Sai Life Science Ltd.	OneSource Specialty Pharma Ltd.	Sanofi Consumer Healthcare India Ltd.
Price (₹)	₹1,577	₹628.95	₹780	₹968	₹1,320	₹4,075
% Change	3.47%	-5.40%	-0.01%	2.83%	3.96%	0.75%
Revenue TTM (₹ Cr)	-	-	₹1,598.19	₹2,169.86	₹1,419.33	₹798.10
Net Profit TTM (₹ Cr)	-	-	₹206.20	₹332.94	₹20.10	₹217.90
PE TTM	-	-	62.20	61.50	754.90	43.10
1 Year Return	48.29	6.51	60.63	37.17	3.9	-12.48
ROCE	30.24	34.78	34.76	12.51	3.26	-

Similar Stocks

AKUMS

Akums Drugs & Pharmaceuticals Ltd.

₹ 474.00

-0.91%

BLUEJET

Blue Jet Healthcare Ltd

₹ 391.40

+9.99%

CONCORDBIO

Concord Biotech Ltd.

₹ 1103.00

+0.46%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 687.60

-1.60%

SUPRIYA

Supriya Lifescience Ltd.

₹ 670.00

-1.17%

ACUTAAS

Acutaas Chemicals Ltd.

₹ 2138.50

+1.52%

ALIVUS

Alivus Life Sciences Ltd.

₹ 901.15

-1.08%

COHANCE

Cohance Lifesciences Ltd.

₹ 315.10

+3.18%

ERIS

Eris Lifesciences Ltd.

₹ 1358.00

+1.16%

SYNGENE

Syngene International Ltd.

₹ 448.60

+1.33%

APLLTD

Alembic Pharmaceuticals Ltd.

₹ 774.90

+1.55%

STAR

Strides Pharma Science Ltd.

₹ 872.90

+0.37%

GRANULES

Granules India Ltd.

₹ 598.00

-0.18%

FDC

FDC Ltd.

₹ 383.00

+3.82%

SHILPAMED

Shilpa Medicare Ltd.

₹ 329.00

+1.29%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 900.00

+3.15%

NATCOPHARM

Natco Pharma Ltd.

₹ 886.00

-0.64%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 1739.00

+2.77%

MARKSANS

Marksans Pharma Ltd.

₹ 179.32

+0.53%

SANOFI

Sanofi India Ltd.

₹ 4080.00

+1.34%

PGHL

Procter & Gamble Health Ltd.

₹ 5080.00

+1.21%

JSLL

Jeena Sikho Lifecare Ltd.

₹ 674.90

-2.16%

FAQ's on NEULANDLAB

What is the current share price of Neuland Laboratories Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Neuland Laboratories Ltd. is ₹ 13507 on the NSE and ₹ 13525 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Neuland Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Neuland Laboratories Ltd. is approximately ₹ 17514.1 Cr.

What are the PE and PB ratios for Neuland Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Neuland Laboratories Ltd. is 97.8, and the Price-to-Book (PB) ratio is 10.8.

What is the 52-Week High and Low for Neuland Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Neuland Laboratories Ltd. shares was ₹ 19747, and the lowest price was ₹ 10190.7.

What is the current dividend yield for Neuland Laboratories Ltd.?

As of 6 June 2025, the dividend yield for Neuland Laboratories Ltd. is 0.1%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Neuland Laboratories Ltd.?

Significant shareholdings in Neuland Laboratories Ltd. typically include entities such as:

Promoter
Public
FII
Mutual Funds
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Neuland Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Neuland Laboratories Ltd. is often compared with other major players such as Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies, Sudeep Pharma and Curis Lifesciences for analysis and benchmarking.

What is the latest dividend information for Neuland Laboratories Ltd.?

Neuland Laboratories Ltd. last declared a FINAL dividend of ₹ 12 per share for the financial period ending 2025. The record date was set as 2025-07-18, and the payment was/is scheduled around 2025-07-18. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy